Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
CiplaMed 2.0 leverages advanced analytics and automation
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated